(ALAB) Astera Labs, Common Stock - Ratings and Ratios
Connectivity Platform, Retimers, Controllers, Switches
ALAB EPS (Earnings per Share)
ALAB Revenue
Description: ALAB Astera Labs, Common Stock September 29, 2025
Astera Labs, Inc. (NASDAQ: ALAB) is a California-based fabless semiconductor firm that builds and sells connectivity solutions aimed at cloud-scale and AI data-center infrastructure. Founded in 2017, the company targets hyperscalers and system OEMs with a portfolio that combines hardware and software to manage high-speed interconnects.
The core offering is an “intelligent connectivity platform” that fuses mixed-signal ASICs-featuring embedded microcontrollers, sensors, and retimers-with the COSMOS software suite. COSMOS provides link-level diagnostics, fleet-wide resource orchestration, and reliability-aware (RAS) management, enabling operators to monitor and optimize thousands of ports in real time.
Product lines include PCIe 5.0/CXL smart DSP retimers, Ethernet smart cable modules, CXL memory-connectivity controllers, and programmable fabric switches. These components are positioned to address the rapid migration to PCIe 5.0 and CXL standards, which analysts estimate will drive $12-$15 billion of incremental spend in the data-center interconnect market through 2028.
Recent financial disclosures show a year-over-year revenue growth of ~68 % in Q2 2024, with gross margins expanding to 55 % as the firm scales volume and shifts to higher-margin software licensing. The broader semiconductor connectivity segment is benefiting from a 10-12 % CAGR in AI-driven workloads, while supply-chain tightening on advanced silicon continues to create entry barriers for new competitors.
If you want a data-driven, quantitative assessment of ALAB’s valuation relative to its peers, a deeper dive on ValueRay’s platform can provide the metrics and scenario analysis you need.
ALAB Stock Overview
| Market Cap in USD | 27,421m |
| Sub-Industry | Semiconductors |
| IPO / Inception | 2024-03-20 |
ALAB Stock Ratings
| Growth Rating | 77.5% |
| Fundamental | 62.3% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 95.7% |
| Analyst Rating | 4.47 of 5 |
ALAB Dividends
Currently no dividends paidALAB Growth Ratios
| Growth Correlation 3m | 18.2% |
| Growth Correlation 12m | 46.6% |
| Growth Correlation 5y | 67.4% |
| CAGR 5y | 161.73% |
| CAGR/Max DD 3y (Calmar Ratio) | 2.54 |
| CAGR/Mean DD 3y (Pain Ratio) | 5.86 |
| Sharpe Ratio 12m | 0.32 |
| Alpha | 106.99 |
| Beta | |
| Volatility | 104.68% |
| Current Volume | 3950.3k |
| Average Volume 20d | 5274.1k |
| Stop Loss | 158.3 (-7%) |
| Signal | 0.33 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (100.2m TTM) > 0 and > 6% of Revenue (6% = 36.3m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 11.78pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 177.4% (prev 360.3%; Δ -182.9pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 249.1m > Net Income 100.2m (YES >=105%, WARN >=100%) |
| Net Debt (-131.1m) to EBITDA (46.6m) ratio: -2.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 11.10 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (178.1m) change vs 12m ago 14.76% (target <= -2.0% for YES) |
| Gross Margin 75.52% (prev 77.33%; Δ -1.81pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 55.38% (prev 25.07%; Δ 30.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.99 (EBITDA TTM 46.6m / Interest Expense TTM -42.8m) >= 6 (WARN >= 3) |
Altman Z'' 4.53
| (A) 0.85 = (Total Current Assets 1.18b - Total Current Liabilities 106.4m) / Total Assets 1.27b |
| (B) -0.10 = Retained Earnings (Balance) -125.8m / Total Assets 1.27b |
| (C) 0.04 = EBIT TTM 42.3m / Avg Total Assets 1.09b |
| (D) -0.91 = Book Value of Equity -122.9m / Total Liabilities 135.7m |
| Total Rating: 4.53 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.29
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 0.80% = 0.40 |
| 3. FCF Margin 34.74% = 7.50 |
| 4. Debt/Equity 0.03 = 2.50 |
| 5. Debt/Ebitda -2.81 = 2.50 |
| 6. ROIC - WACC (= -11.08)% = -12.50 |
| 7. RoE 9.94% = 0.83 |
| 8. Rev. Trend 92.95% = 6.97 |
| 9. EPS Trend 81.77% = 4.09 |
What is the price of ALAB shares?
Over the past week, the price has changed by +8.94%, over one month by -14.35%, over three months by +37.27% and over the past year by +133.68%.
Is Astera Labs, Common Stock a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ALAB is around 163.18 USD . This means that ALAB is currently overvalued and has a potential downside of -4.17%.
Is ALAB a buy, sell or hold?
- Strong Buy: 9
- Buy: 7
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ALAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 188.2 | 10.5% |
| Analysts Target Price | 188.2 | 10.5% |
| ValueRay Target Price | 193.1 | 13.4% |
ALAB Fundamental Data Overview October 27, 2025
P/E Trailing = 208.8228
P/E Forward = 107.5269
P/S = 45.2832
P/B = 30.6763
Beta = None
Revenue TTM = 605.5m USD
EBIT TTM = 42.3m USD
EBITDA TTM = 46.6m USD
Long Term Debt = 1.29m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 4.67m USD (from shortTermDebt, last quarter)
Debt = 32.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -131.1m USD (from netDebt column, last quarter)
Enterprise Value = 26.39b USD (27.42b + Debt 32.3m - CCE 1.07b)
Interest Coverage Ratio = -0.99 (Ebit TTM 42.3m / Interest Expense TTM -42.8m)
FCF Yield = 0.80% (FCF TTM 210.4m / Enterprise Value 26.39b)
FCF Margin = 34.74% (FCF TTM 210.4m / Revenue TTM 605.5m)
Net Margin = 16.54% (Net Income TTM 100.2m / Revenue TTM 605.5m)
Gross Margin = 75.52% ((Revenue TTM 605.5m - Cost of Revenue TTM 148.2m) / Revenue TTM)
Gross Margin QoQ = 75.84% (prev 74.89%)
Tobins Q-Ratio = 20.75 (Enterprise Value 26.39b / Total Assets 1.27b)
Interest Expense / Debt = -132.4% (Interest Expense -42.8m / Debt 32.3m)
Taxrate = -1.11% (negative due to tax credits) (-560.0k / 50.7m)
NOPAT = 42.8m (EBIT 42.3m * (1 - -1.11%)) [negative tax rate / tax credits]
Current Ratio = 11.10 (Total Current Assets 1.18b / Total Current Liabilities 106.4m)
Debt / Equity = 0.03 (Debt 32.3m / totalStockholderEquity, last quarter 1.14b)
Debt / EBITDA = -2.81 (Net Debt -131.1m / EBITDA 46.6m)
Debt / FCF = -0.62 (Net Debt -131.1m / FCF TTM 210.4m)
Total Stockholder Equity = 1.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.88% (Net Income 100.2m / Total Assets 1.27b)
RoE = 9.94% (Net Income TTM 100.2m / Total Stockholder Equity 1.01b)
RoCE = 4.19% (EBIT 42.3m / Capital Employed (Equity 1.01b + L.T.Debt 1.29m))
RoIC = 4.24% (NOPAT 42.8m / Invested Capital 1.01b)
WACC = 15.32% (E(27.42b)/V(27.45b) * Re(15.34%) + (debt cost/tax rate unavailable))
Discount Rate = 15.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 118.0%
[DCF Debug] Terminal Value 45.13% ; FCFE base≈143.7m ; Y1≈94.3m ; Y5≈43.1m
Fair Price DCF = 2.35 (DCF Value 390.9m / Shares Outstanding 166.2m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 81.77 | EPS CAGR: 137.8% | SUE: 1.86 | # QB: 1
Revenue Correlation: 92.95 | Revenue CAGR: 115.9% | SUE: 2.72 | # QB: 2
Additional Sources for ALAB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle